Contrast medium, oral administration

Contrast medium, oral administration
Primary use
Diagnosis / Measurement / Monitoring
Type of medical device or related product
Solutions and reagents
General vs. specific use (health condition)
General
Intended population age
Later adults (over 64 years)
Adults (20 to 64 years)
Adolescent (10 to 19 years)
Intended population sex
All
Level of technical knowledge
Specialized clinical
Capital
No
Reusable
No
Requirements
None
Service delivery platforms / Healthcare levels
Second-level and third-level hospital services and specialized outpatient services
Healthcare unit
Medical imaging
EMDN related code(s)
Z11039085
VARIOUS RADIODIAGNOSTIC AND INTERVENTIONAL INSTRUMENTS - CONSUMABLES
The code(s) and term(s) in this section were observed and retrieved from public databases and have not been validated by health regulatory authorities. Please consult your regulatory agency and EMDN site: https://webgate.ec.europa.eu/dyna2/emdn
GMDN related code(s)
40714
X-ray contrast medium, gastrointestinal tract administration (A chemical substance/formulation that is administered to the patient, orally or as an enema (including air or other gases), in order to temporarily enable or enhance the ability to differentially visualize targeted body structures on x-ray images. It is delivered to the patient via the gastrointestinal (GI) tract and intended to increase the ability to differentiate between normal and pathological conditions when analysing or interpreting medical images and information generated by a diagnostic x-ray system. After application, this device cannot be reused.)
The medical device term(s), code(s) and definition(s) in this section were retrieved from databases external to WHO. As there might be more than one name, definition and “Nomenclature Code” related to the specific medical device, please consult https://gmdnagency.org GMDN ®. © GMDN Agency 2005-2025 
WHO related resources
Decommissioning
WHO resources on medical devices